Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The US Department of Health and Human Services (HHS) Office of Inspector General (OIG) says the National Institutes of Health (NIH) has failed to hold NIH-funded researchers accountable for publishing clinical trial data. The watchdog agency has made several recommendations to ensure better transparency in the future.
JCVI advised the UK government to adopt Pfizer’s Comirnaty and Moderna’s Spikevax for the autumn booster program in addition to Moderna’s bivalent COVID-19 vaccine for adults, with Novavax’s recently approved vaccine as backup. For adolescents, JC...
The US Food and Drug Administration (FDA) on Tuesday finalized its guidance explaining its policies for replacement reagents and instrument families for in vitro diagnostics (IVDs), replacing an earlier policy issued in 2003.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
The US Food and Drug Administration has developed draft guidance for manufacturers of hydrogen peroxide-based contact lens care products (HPCP) to consider when labeling their solutions in response to a number of adverse events, including cases wh...
This article examines the impact of diverging regulations and practices for food supplements and specialized food products since the UK left the EU market in 2020.  Keywords – Brexit, divergence, food supplements, UK, Norther...
In the first year and a half of the COVID-19 pandemic, public funding played a major role in the development of COVID-19 therapeutics and vaccines, according to recent research published in JAMA Network Open .
RAPS will recognize the recipients of each award at RAPS Convergence 2022.
The Regulatory Affairs Professionals Society (RAPS) has named 10 exceptional senior regulatory professionals to the distinguished ranks of the RAPS Fellows Program.
The US Food and Drug Administration (FDA) issued a warning letter to Emergent BioSolutions subsidiary Cangene BioPharma outlining violations of current good manufacturing practice (CGMP) regulations found during a February 2022 inspection of their...
After pressure from the Biden Administration, the US Food and Drug Administration finalized a much-anticipated rule that allows certain air conduction hearing aids to be available over-the-counter (OTC) without the need for a hearing exams or fitt...
Immune checkpoint inhibitors (ICIs) improve patient-reported outcomes (PROs) if they are used alone or together with other anticancer drugs, according to recent research published in JAMA Network Open .
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
The effort is based on Philippine FDA’s push to increase reliance on the work of other regulators. Last year, the World Health Organization released a document on good reliance practices that supported the use of the output of other regulatory age...